Abstract

Introduction:Extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae confer antibiotic resistance to broad-spectrum penicillins, cephalosporins, using ESBL genes CTX-M, TEM, SHV, which are encoded in bacterial plasmid genome. Methods: We compared plasmid CTX-M, TEM, and SHV ESBL gene combinations in ESBL producing Escherichia coliand Klebsiella pneumoniae. Altogether, 136 ESBL producing Enterobacteriaceae isolation cases were analyzed. Results:The ESBL producing Enterobacteriaceae, mostly K. pneumoniae (n = 66; 48.53%), E. coli (n = 36; 26.47%), were isolated from 52 (38.2%) female and 84 (61.8%) male patients from Riga East Clinical University Hospital. Overall,132 isolates (97.06%) registered positive for the plasmid CTX-M gene, 97 isolates (71.32%) for the plasmid TEM gene, and 87 isolates (63.97%) for the plasmid SHV gene.Patients with the three ESBL plasmid gene (CTX-M+ TEM+ SHV+) combination were significantly older (67.11 ± 14.16 years) than patients with other gene combinations (59.63 ± 18.14 years; p = 0.047). Plasmid SHV gene frequency was higher in K. pneumoniae (p < 0.001). The K. pneumoniae mostly presented with the three plasmid ESBL gene (CTX-M+ TEM+ SHV+) combination, whereas E. coli presented with other gene combinations (p = 0.014). Conclusions: Klebsiella Pneumoniae, more often, presented with the plasmid SHV ESBL gene and the three ESBL gene (CTX-M+ TEM+ SHV+) combination, compared to E. coli. Older patients with ESBL producing Enterobacteriaceae infection, more often, presented with the three ESBL gene (CTX-M+ TEM+ SHV+) combination, compared to younger patients with the infection.

Highlights

  • Extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae confer antibiotic resistance to broad-spectrum penicillins, cephalosporins, using ESBL genes CTX-M, TEM, SHV, which are encoded in bacterial plasmid genome

  • Since the first outbreak in 1983, reports of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae have increased due to extensive antibiotic consumption and widespread gene mutation, conferring resistance to extended spectrum penicillins and cephalosporins (Coque, Baquero, & Canton, 2008; Alekshun & Levy, 2007)

  • ESBL producing Enterobacteriaceae were isolated from wound (n = 44, 32.35%), urine (n = 25, 18.38%), bronchoalveolar fluid (n = 25, 18.38%), and abdominal cavity (n = 20, 14.71%) biomaterial. (Figure 1)

Read more

Summary

Introduction

Extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae confer antibiotic resistance to broad-spectrum penicillins, cephalosporins, using ESBL genes CTX-M, TEM, SHV, which are encoded in bacterial plasmid genome. Adequate empiric antibacterial therapy in ESBL producing microorganism infection cases should be started early, preferably within 72 hours of confirmation of ESBL producing bacteria (Tumbarello et al, 2007), and should be based on local antibacterial resistance patterns. This is often challenging due to high antimicrobial resistance and lack of local resistance pattern data (The New β-Lactamases NEJM, 2015 ; Peralta et al, 2012). It is essential to determine the local ESBL producing bacteria strains and plasmid extended-spectrum beta-lactamase gene frequency in order to establish local resistance patterns and start an effective empiric antibacterial treatment (Tacconelli et al, 2014)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call